Kymera Appoints Noah Goodman as Chief Business Officer
Company - People | Apr 09, 2025 | EIN

Kymera Therapeutics, a biopharmaceutical company from Boston, announced Noah Goodman as the new Chief Business Officer to lead their business development strategy. With extensive experience in the life sciences sector, Goodman has held notable positions at Chroma Medicine, Cadent Therapeutics, Seres Therapeutics, Spark Therapeutics, and Easton Associates. Kymera is known for pioneering targeted protein degradation (TPD) to create medicines for immunological diseases. CEO Nello Mainolfi is confident this new leadership move will support the company’s growth and expanding pipeline. Goodman expressed excitement to join during this crucial phase of development. Founded in 2016, Kymera has set recognition as a leading workplace while deploying solutions for diseases otherwise unresolved by conventional therapeutics.
Sectors
- Biopharmaceuticals
- Life Sciences
Geography
- United States – Kymera Therapeutics is based in Boston, Massachusetts, USA, and operates within the American biopharmaceutical market.
Industry
- Biopharmaceuticals – Kymera Therapeutics operates in the biopharmaceutical industry, working on groundbreaking treatments for immunological diseases.
- Life Sciences – The life sciences sector is relevant given Kymera's focus on targeted protein degradation and Noah Goodman's background in this field.
Financials
Participants
Name | Role | Type | Description |
---|---|---|---|
Kymera Therapeutics, Inc. | Company appointing new CBO | Companies | A clinical-stage biopharmaceutical company focused on developing oral small molecule degrader medicines. |
Noah Goodman | Chief Business Officer | People | Recently appointed CBO of Kymera Therapeutics with extensive experience in the life sciences sector. |
Chroma Medicine | Previous Employer of Noah Goodman | Companies | A company where Noah Goodman held senior leadership roles before joining Kymera. |
Cadent Therapeutics | Previous Employer | Companies | Goodman worked here as Executive Director before its acquisition by Novartis. |
Seres Therapeutics | Previous Employer | Companies | Goodman led collaborations and licensing transactions here. |
Spark Therapeutics | Previous Employer | Companies | Goodman worked in the business development department. |
Easton Associates | Previous Employer | Companies | A boutique life sciences consultancy where Goodman served as a management consultant. |